News Category:

Funding and Deals

New grant will fund research of biomechanical markers in glaucoma

glaucoma markersThis study may explain why individuals of African descent are at the greatest risk of developing glaucoma.Massimo A. Fazio, Ph.D., assistant professor in the University of Alabama at Birmingham Department of Ophthalmology, and Christopher A. Girkin M.D., have received a four-year, $2.55 million R01 ...

Medical researchers thankful for $2 billion NIH funding increase

NIH will receive $2 billion in additional resources for the final five months of this fiscal year, was a delightful surprise.

Soluble Therapeutics Acquires Dilyx Biotechnologies

Soluble Therapeutics Acquires Dilyx Biotechnologies

HudsonAlpha receives $50,000 donation for Chan Training Lab

Chan Training Lab DedicationEducational Outreach at HudsonAlpha expanded its reach to more than 400,000 individuals this year and can continue to expand thanks to Dr. and Mrs. Tony Chan and their generous donation. Since 2009, the University of Alabama in Huntsville Professor Emeritus of Physics and his wife ...
news categories:

Soluble Therapeutics Acquires Dilyx Biotechnologies

Logo - Soluble  TherapeuticsSoluble Therapeutics Inc. announced on October 1, 2014 the acquisition of Seattle-based Dilyx Biotechnologies as a wholly owned subsidiary of Soluble Therapeutics. All of Dilyx operations will be moved to Birmingham. The acquisition of Dilyx will expand Soluble Therapeutics’ footprint in the ...

Alabama’s New Crowdfunding Law

Photo - Senator Arthur OrrUnder the new legislation, signed into law by Gov. Robert Bentley in April and drafted by Sen. Arthur Orr with help from the Alabama Securities Commission,  the crowdfunding exemption allows Alabama entrepreneurs to raise money from investors only in Alabama. A for-profit corporation/entity ...
news categories: ,

Alabama LaunchPad Application Deadline Approaching

Registration is open for the seventh annual Economic Development Partnership of Alabama’s Alabama Launchpad Start-up Competition for teams in the proof of concept stage.

CFDRC Developing Physiologically Realistic in vitro Tumor Microenvironment Platform

SynVivo-Tumor offers real-time analysis and visualization of drug delivery and cellular interactions and was showcased at the December ASCB meeting in San Francisco.

Southeast Venture Conference seeking presenting companies

The Southeast Venture Conference, which is set for March in Charlotte, has opened its review and registration process for startups and emerging growth technology firms that want to present to potential investors.

news categories:

Gulf Coast Angel Network Inks Deal with Angel Investor Management Group

The Gulf Coast Angel Network (“GCAN”) has signed a contract with the Angel Investor Management Group (“AIM”) to manage its network, deal flow and due diligence. Dr. Michael Chambers, GCAN Chairman of the Board, announced the new relationship stating, “We are very excited to enter into this relationship because it offers our members a uniform, structured due diligence process and increased deal flow.”

news categories: